New Advances in Cardiorenal Syndrome: 2nd Edition

Dear colleagues,

As the Guest Editor, it is my privilege to invite you to discover new and relevant research results on cardiorenal syndrome in the upcoming second edition of our Special Issue titled “Advances in Cardiorenal Syndrome” (https://www.mdpi.com/journal/jcm/special_issues/Advances_Cardiorenal_Syndrome). The new collection will cover the “renal factor” in cardiorenal syndrome that has become more relevant to both nephrologists and cardiologists. In addition, the prevention of renal replacement therapies via the optimization of medical therapy is the focus. Since the conception of this Special Issue, sodium-glucose-cotransporter-2 inhibitors have demonstrated a huge potential as cardiorenal medication in order to delay the onset of renal replacement therapies. Other upcoming medications, including finerenone, may add value as cardiorenal medications as well. Last, the pathogenesis of uremic cardiomyopathy, a new disease entity for heart failure during acute or chronic kidney failure is being reviewed in the upcoming Special Issue.

We are glad to have you here to follow up on these and other upcoming publications. Authors should feel free to submit their work. The diagnostics of and therapies for cardiorenal syndrome are topics of interest. We believe that this second edition will be an essential addition to the collective knowledge in the field.

Dr. Rainer Ullrich Pliquett
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cardiorenal syndrome
• outcome
• hyperkalemia
• acute kidney injury
• chronic kidney disease
• chronic heart failure

• New Advances in Cardiorenal Syndrome in Journal of Clinical Medicine (6 articles)

Title: Sodium-glucose-cotransporter -2 inhibitor therapy in cardiorenal medicine - role of glucose-mediated oxidative stress
Authors: K. Schröder
Affiliation: Institut für Kardiovaskuläre Physiologie, Goethe-Universität, Frankfurt, Germany

Title: Uremic Cardiomyopathy presenting as acute heart failure with pericardial effusion: a case-series report and review of the literature.
Authors: A. Janikowsia
Affiliation: Germany

Title: Potassium-induced aldosterone activation as a therapeutic goal in cardiorenal syndrome
Authors: A. Adeagbo
Affiliation: Germany

Title: Acute kidney injury during sepsis: prognostic role of comorbidity heart failure
Authors: Jens Soukup
Affiliation: Germany

Title: Review of Bradycardia-associated Renal failure, Atrioventricular block, Shock, Hyperkalemia (BRASH) syndrome - a common cause of cardiorenal syndrome
Authors: R. Pliquett
Affiliation: Germany